| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride |
| Available forms, composition and doses of Ondansetron: |
| Injectable; Injection; Ondansetron Hydrochloride 2 mg / ml |
| Ondansetron medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Akorn |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Novatron | Ondansetron Hydrochloride | Radicura Pharmaceuticals |
| Nozuca | Ondansetron Hydrochloride | Darvys Pharma; RBC-MDC Corporation |
| Odanostin | Ondansetron Hydrochloride | Ifars Pharmaceutical Laboratories |
| Odanostin Forte | Ondansetron Hydrochloride | Ifars Pharmaceutical Laboratories |
| Ondansertron | Ondansetron Hydrochloride | Taro Pharmaceutical Industries |
| Ondansetron | Ondansetron Hydrochloride | Amneal Pharmaceuticals |
| Ondansetron | Ondansetron Hydrochloride | Apotex |
| Ondansetron | Ondansetron Hydrochloride | Aurobindo |
| Ondansetron | Ondansetron Hydrochloride | Barr Laboratories |
| Ondansetron | Ondansetron Hydrochloride | Baxter |